Similar articles

• Statin-associated myopathy with normal creatine kinase levels.

  Phillips PS, Haas RH, Bannykh S, Hathaway S, Gray NL, Kimura BJ, Vladutiu GD, England JD; Scripps Mercy Clinical Research Center. Phillips PS, et al. Ann Intern Med. 2002 Oct 1;137(7):581-5. doi: 10.7326/0003-4819-137-7-200210010-00009. Ann Intern Med. 2002. PMID: 12353945 Clinical Trial.
• [Myopathy due to statins, a dose-dependent effect, and of what kind?].

  León Vázquez F, Llanes De Torres R, Morón Merchante I. León Vázquez F, et al. Aten Primaria. 2002 Jul-Aug;30(3):188. doi: 10.1016/s0212-6567(02)79002-1. Aten Primaria. 2002. PMID: 12139858 Free PMC article. Spanish. No abstract available.
• Muscle symptoms associated with statins: a series of twenty patients.

  Soininen K, Niemi M, Kilkki E, Strandberg T, Kivistö KT. Soininen K, et al. Basic Clin Pharmacol Toxicol. 2006 Jan;98(1):51-4. doi: 10.1111/j.1742-7843.2006.pto_193.x. Basic Clin Pharmacol Toxicol. 2006. PMID: 16433891
• Peripheral neuropathy and lipid-lowering therapy.

  Ziajka PE, Wehmeier T. Ziajka PE, et al. South Med J. 1998 Jul;91(7):667-8. doi: 10.1097/00007611-199807000-00013. South Med J. 1998. PMID: 9671841 Review.
• [Interaction risk with statin switch].

  Molden E, Westergren T. Molden E, et al. Tidsskr Nor Laegeforen. 2007 Feb 15;127(4):428-31. Tidsskr Nor Laegeforen. 2007. PMID: 17304269 Review. Norwegian.